KFP
BIIB icon

KMG Fiduciary Partners’s Biogen BIIB Stock Holding History

KMG Fiduciary Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,114
Closed -$288K – 234
2023
Q4 		$288K Sell
1,114
-386
-26% -$94.8K 0.03% 205
2023
Q3 		$386K Sell
1,500
-196
-12% -$52.4K 0.05% 182
2023
Q2 		$483K Sell
1,696
-626
-27% -$186K 0.06% 175
2023
Q1 		$646K Sell
2,322
-371
-14% -$103K 0.09% 162
2022
Q4 		$746K Sell
2,693
-261
-9% -$73.7K 0.12% 139
2022
Q3 		$789K Sell
2,954
-3,741
-56% -$795K 0.15% 119
2022
Q2 		$1.36M Sell
6,695
-707
-10% -$145K 0.25% 90
2022
Q1 		$1.56M Sell
7,402
-1,922
-21% -$418K 0.25% 90
2021
Q4 		$2.24M Sell
9,324
-3,984
-30% -$1.02M 0.35% 74
2021
Q3 		$3.77M Sell
13,308
-1,029
-7% -$337K 0.64% 42
2021
Q2 		$4.96M Sell
14,337
-148
-1% -$44.8K 0.88% 29
2021
Q1 		$4.05M Buy
14,485
+148
+1% +$39.9K 0.79% 34
2020
Q4 		$3.53M Buy
14,337
+1,287
+10% +$332K 0.74% 36
2020
Q3 		$3.7M Buy
13,050
+1,064
+9% +$297K 0.92% 32
2020
Q2 		$3.21M Buy
11,986
+809
+7% +$243K 0.89% 35
2020
Q1 		$3.54M Buy
11,177
+430
+4% +$130K 1.15% 28
2019
Q4 		$3.19M Buy
10,747
+13
+0.1% +$3.61K 0.97% 36
2019
Q3 		$2.5M Sell
10,734
-200
-2% -$46.6K 0.85% 35
2019
Q2 		$2.56M Buy
10,934
+162
+2% +$37.4K 0.92% 34
2019
Q1 		$2.55M Sell
10,772
-1,553
-13% -$489K 0.97% 32
2018
Q4 		$3.71M Buy
+12,325
New +$3.93M 1.69% 21

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KMG Fiduciary Partners's BIIB Position: Q1 2024 in Review

KMG Fiduciary Partners sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,114 shares — an estimated $288K sold.

KMG Fiduciary Partners first reported a position in BIIB in Q4 2018 and held it in 21 quarters. The position peaked at $4.96M in Q2 2021. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • KMG Fiduciary Partners reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • KMG Fiduciary Partners sold 1,114 Biogen shares in Q1 2024, an estimated $288K.
  • KMG Fiduciary Partners first reported a position in Biogen in Q4 2018 and held it in 21 quarters.
  • KMG Fiduciary Partners's Biogen position peaked at $4.96M in Q2 2021.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on KMG Fiduciary Partners's 13F filing for Q1 2024, filed 10 Apr 2024.